home / stock / nonof / nonof news


NONOF News and Press, Novo-Nordisk A/S From 05/11/24

Stock Information

Company Name: Novo-Nordisk A/S
Stock Symbol: NONOF
Market: OTC
Website: novonordisk.com

Menu

NONOF NONOF Quote NONOF Short NONOF News NONOF Articles NONOF Message Board
Get NONOF Alerts

News, Short Squeeze, Breakout and More Instantly...

NONOF - U.S. dialysis volumes expected to rebound in 2024 despite GLP-1 impact

2024-05-11 12:13:54 ET More on Fresenius Medical Care Fresenius Medical Care AG (FMS) Q1 2024 Earnings Call Transcript Broyhill - Fresenius Medical Care: Correctly Focused On Increasing Margins And Returns Fresenius Medical Care AG (FMS) Q4 2023 Earnings Call Transcr...

NONOF - One in eight U.S. adults admits to GLP-1 usage as public awareness climbs

2024-05-10 10:16:35 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: Great Time To Divest Before It Potentially Crashes Eli Lilly Remains Expensive Here - Minimal Margin Of Safety The FTC Cracks Down On Novo Nordisk's Ozempic Dividend Roundup: Eli Lilly, A...

NONOF - Novo Nordisk A/S (NVO) Q1 2024 Earnings Call Transcript

2024-05-02 12:21:14 ET Novo Nordisk A/S (NVO) Q1 2024 Earnings Conference Call May 2, 2024 07:00 a.m. ET Company Participants Lars Fruergaard Jørgensen - Chief Executive Officer Camilla Sylvest - Executive Vice President, Head of Commercial Strategy & Corpor...

NONOF - Novo Nordisk GAAP EPADR of DKK 5.68, revenue of DKK 65.35B; updates FY24 outlook

2024-05-02 01:40:07 ET More on Novo Nordisk: Novo Nordisk: Medicare Coverage To Unlock Another Big Market For Wegovy Novo Nordisk Remains The Better Buy After A Moderate Pullback Novo Nordisk: The Moat Won't Last Forever Novo, Teva, AstraZeneca issued FTC war...

NONOF - Amgen Stock: Recent Weakness Is Not A Buying Opportunity Yet

2024-05-01 17:07:44 ET Summary Amgen Inc. shares have dropped some 20% since reaching an all-time high in February due to a below-consensus outlook and patent concerns. The company's four pillars of growth are General Medicine, Oncology, Inflammatory Diseases, and Rare Diseases. ...

NONOF - Eli Lilly raises guidance on weight loss momentum

2024-04-30 07:31:21 ET More on Eli Lilly Eli Lilly And The Alzheimer's Dilemma (Rating Upgrade) Wall Street Lunch: Lilly In Limelight Eli Lilly: Three Threats To Its Huge Rally Eli Lilly Non-GAAP EPS of $2.58 beats by $0.09, revenue of $8.77B misses by $160M ...

NONOF - Artisan International Explorer Fund Q1 2024 Commentary

2024-04-28 12:35:00 ET Summary Artisan Partners is an independent investment management firm focused on providing high value-added, active investment strategies to sophisticated clients globally. We outperformed our benchmark by about 225bps this quarter. Our top two contribut...

NONOF - Novo Nordisk comes under Senate probe over pricing for weight loss drugs

2024-04-24 15:42:21 ET More on Novo Nordisk Novo Nordisk Remains The Better Buy After A Moderate Pullback Novo Nordisk: The Moat Won't Last Forever Shaping The Future Of Obesity Treatment: GLP-1 Agonists At The Forefront 3.6M Medicare patients could qualify f...

NONOF - Artisan International Fund Q1 2024 Commentary

2024-04-24 10:00:00 ET Summary Artisan Partners is an independent investment management firm focused on providing high value-added, active investment strategies to sophisticated clients globally. The portfolio meaningfully beat the benchmark MSCI EAFE Index, as well as the seconda...

NONOF - Artisan Global Equity Fund Q1 2024 Commentary

2024-04-24 09:30:00 ET Summary Artisan Partners is an independent investment management firm focused on providing high value-added, active investment strategies to sophisticated clients globally. The portfolio solidly outperformed the MSCI AC World Index. Holdings in health ca...

Previous 10 Next 10